XERIS PHARMACEUTICALS, INC.

Basic Information

3208 Red River Street
Suite 300
Austin, TX, 78705-2659

Company Profile

n/a

Additional Details

Field Value
DUNS: 609377135
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Glucagon Mini-Dosing Pen for Treatment of Hypoglycemia

    Amount: $451,756.00

    DESCRIPTION (provided by applicant): The program outlined in this application has been designed to accelerate the development and commercialization of a Glucagon Mini-Dose Pen to change the paradigm f ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. Development of an Electromyographically Controlled Electrolarynx Voice Prosthesis

    Amount: $678,969.00

    DESCRIPTION (provided by applicant): The program outlined in this application has been designed to accelerate the development and commercialization of a Glucagon Mini-Dose Pen to change the paradigm f ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump

    Amount: $713,733.00

    DESCRIPTION (provided by applicant): The objective of this program is to further the development of a novel, stable, non-aqueous glucagon formulation as an integral component of a bi-hormonal (insulin ...

    SBIR Phase II 2013 Department of Health and Human Services
  4. Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump

    Amount: $343,124.00

    DESCRIPTION (provided by applicant): The objective of this program is to further the development of a novel, stable, non-aqueous glucagon formulation as an integral component of a bi-hormonal (insulin ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Improved Hypoglycemia Rescue Device

    Amount: $994,123.00

    DESCRIPTION (provided by applicant): The objective of this project is to demonstrate the safety, pharmacokinetics and initial efficacy of a ready-to-use Glucagon Rescue Pen that will deliver a very lo ...

    SBIR Phase II 2011 Department of Health and Human Services
  6. IMPROVED HYPOGLYCEMIA RESCUE DEVICE

    Amount: $157,478.00

    DESCRIPTION (provided by applicant): The objective of this program is to develop of a clinical prototype, semi-solid drug formulation and auto-injector pen that deliver microliter volumes of a glucago ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government